Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 11b PGE2 cPLA2i 1.0 BCD110605C16 0.081 pmol/ml of medium
- 11b PGE2 cPLA2i 1.0 BCD110605C18 0.035 pmol/ml of medium
- 11b PGE2 cPLA2i 1.0 BCD110605C17 0.019 pmol/ml of medium
- 11b PGE2 cPLA2i 4.0 BCD110605C34 0.024 pmol/ml of medium
- 11b PGE2 cPLA2i 4.0 BCD110605C36 0.054 pmol/ml of medium
- 11b PGE2 cPLA2i 4.0 BCD110605C35 0.046 pmol/ml of medium
- 11b PGE2 cPLA2i 20.0 BCD110605C53 0.026 pmol/ml of medium
- 11b PGE2 cPLA2i 20.0 BCD110605C54 0.031 pmol/ml of medium
- 11b PGE2 cPLA2i 20.0 BCD110605C52 0.052 pmol/ml of medium
- 11b PGE2 PLDi 1.0 BCD110605C10 0.041 pmol/ml of medium
- 11b PGE2 PLDi 1.0 BCD110605C12 0.108 pmol/ml of medium
- 11b PGE2 PLDi 1.0 BCD110605C11 0.035 pmol/ml of medium
- 11b PGE2 PLDi 4.0 BCD110605C30 0.041 pmol/ml of medium
- 11b PGE2 PLDi 4.0 BCD110605C29 0.03 pmol/ml of medium
- 11b PGE2 PLDi 4.0 BCD110605C28 0.036 pmol/ml of medium
- 11b PGE2 PLDi 20.0 BCD110605C48 0.04 pmol/ml of medium
- 11b PGE2 PLDi 20.0 BCD110605C47 0.054 pmol/ml of medium
- 11b PGE2 PLDi 20.0 BCD110605C46 0.042 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 1.0 BCD110605C19 0.034 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 1.0 BCD110605C21 0.043 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 1.0 BCD110605C20 0.053 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 4.0 BCD110605C39 0.12 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 4.0 BCD110605C37 0.099 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 4.0 BCD110605C38 0.095 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 20.0 BCD110605C55 0.185 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 20.0 BCD110605C57 0.265 pmol/ml of medium
- 11b PGE2 KDO+cPLA2i 20.0 BCD110605C56 0.156 pmol/ml of medium
- 11b PGE2 KDO+PLDi 1.0 BCD110605C15 0.141 pmol/ml of medium
- 11b PGE2 KDO+PLDi 1.0 BCD110605C14 0.099 pmol/ml of medium
- 11b PGE2 KDO+PLDi 1.0 BCD110605C13 0.092 pmol/ml of medium
- 11b PGE2 KDO+PLDi 4.0 BCD110605C32 0.222 pmol/ml of medium
- 11b PGE2 KDO+PLDi 4.0 BCD110605C31 0.312 pmol/ml of medium
- 11b PGE2 KDO+PLDi 4.0 BCD110605C33 0.157 pmol/ml of medium
- 11b PGE2 KDO+PLDi 20.0 BCD110605C49 0.934 pmol/ml of medium
- 11b PGE2 KDO+PLDi 20.0 BCD110605C51 0.422 pmol/ml of medium
- 11b PGE2 KDO+PLDi 20.0 BCD110605C50 0.522 pmol/ml of medium
- 11b PGE2 KDO + ATP 1.0 BCD110605C07 0.083 pmol/ml of medium
- 11b PGE2 KDO + ATP 1.0 BCD110605C09 0.089 pmol/ml of medium
- 11b PGE2 KDO + ATP 1.0 BCD110605C08 0.105 pmol/ml of medium
- 11b PGE2 KDO + ATP 4.0 BCD110605C25 0.168 pmol/ml of medium
- 11b PGE2 KDO + ATP 4.0 BCD110605C26 0.843 pmol/ml of medium
- 11b PGE2 KDO + ATP 4.0 BCD110605C27 0.357 pmol/ml of medium
- 11b PGE2 KDO + ATP 20.0 BCD110605C45 0.575 pmol/ml of medium
- 11b PGE2 KDO + ATP 20.0 BCD110605C43 0.452 pmol/ml of medium
- 11b PGE2 KDO + ATP 20.0 BCD110605C44 0.461 pmol/ml of medium
- 11b PGE2 C 0.0 BCD110605C02 0.02 pmol/ml of medium
- 11b PGE2 C 0.0 BCD110605C01 0.041 pmol/ml of medium
- 11b PGE2 C 0.0 BCD110605C03 0.028 pmol/ml of medium
- 11b PGE2 C 1.0 BCD110605C06 0.025 pmol/ml of medium
- 11b PGE2 C 1.0 BCD110605C05 0.034 pmol/ml of medium